1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
One of these players could win in AI -- and in the healthcare market, in general.
Source: fool.com
Page 42 - Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recursion Pharmaceuticals Today - Breaking & Trending Today
Is Recursion Pharmaceuticals Stock a Buy Now?
The company has grabbed plenty of headlines recently.
Source: fool.com
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 7.7%
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares were up 7.7% during trading on Tuesday . The stock traded as high as $7.30 and last traded at $7.28. Approximately 567,886 shares traded hands during trading, a decline of 82% from the average daily volume of 3,240,086 shares. The stock had previously closed at $6.76. […]
Source: wkrb13.com
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $64,771.65 in Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $7.29, for a total transaction of $64,771.65. Following the completion of the transaction, the director now owns 7,434,075 shares in the […]
Source: dailypolitical.com
Blake Borgeson Sells 8,885 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $7.29, for a total value of $64,771.65. Following the completion of the transaction, the director now owns 7,434,075 shares of the […]
Source: modernreaders.com